Paradoxical synergism and antagonism between serum and the antibacterial activity of colistin.
D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000906:Antibodies; D002228:Carbenicillin / Q000627:therapeutic use; D002462:Cell Membrane; D003091:Colistin / Q000494:pharmacology* / Q000627:therapeutic use; D003165:Complement System Proteins; D004336:Drug Antagonism; D004357:Drug Synergism; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D011955:Receptors, Drug; D012710:Serum Albumin, Bovine; D013307:Streptomycin / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000906:Antibodies; D005839:Gentamicins; D011955:Receptors, Drug; D012710:Serum Albumin, Bovine; D000667:Ampicillin; D003165:Complement System Proteins; D013752:Tetracycline; D002228:Carbenicillin; D013307:Streptomycin; D003091:Colistin